- Home
- ATXS vs ASLE Comparison
ATXS vs ASLE Comparison
Compare ATXS & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- ASLE
- Stock Information
- Founded
- ATXS 2008
- ASLE 2008
- Country
- ATXS United States
- ASLE United States
- Employees
- ATXS N/A
- ASLE N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- ASLE Industrial Specialties
- Sector
- ATXS Health Care
- ASLE Consumer Discretionary
- Exchange
- ATXS Nasdaq
- ASLE Nasdaq
- Market Cap
- ATXS 401.2M
- ASLE 322.4M
- IPO Year
- ATXS 2015
- ASLE N/A
- Fundamental
- Price
- ATXS $4.48
- ASLE $6.16
- Analyst Decision
- ATXS Strong Buy
- ASLE Strong Buy
- Analyst Count
- ATXS 6
- ASLE 3
- Target Price
- ATXS $30.00
- ASLE $8.67
- AVG Volume (30 Days)
- ATXS 501.6K
- ASLE 446.1K
- Earning Date
- ATXS 05-20-2025
- ASLE 05-07-2025
- Dividend Yield
- ATXS N/A
- ASLE N/A
- EPS Growth
- ATXS N/A
- ASLE N/A
- EPS
- ATXS N/A
- ASLE N/A
- Revenue
- ATXS N/A
- ASLE $320,302,000.00
- Revenue This Year
- ATXS N/A
- ASLE $14.51
- Revenue Next Year
- ATXS N/A
- ASLE $18.41
- P/E Ratio
- ATXS N/A
- ASLE N/A
- Revenue Growth
- ATXS N/A
- ASLE N/A
- 52 Week Low
- ATXS $3.56
- ASLE $4.53
- 52 Week High
- ATXS $12.92
- ASLE $9.40
- Technical
- Relative Strength Index (RSI)
- ATXS 38.86
- ASLE 33.59
- Support Level
- ATXS $4.25
- ASLE $6.84
- Resistance Level
- ATXS $5.47
- ASLE $7.18
- Average True Range (ATR)
- ATXS 0.35
- ASLE 0.29
- MACD
- ATXS 0.01
- ASLE 0.01
- Stochastic Oscillator
- ATXS 27.45
- ASLE 28.57
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.